Enbrel etanercept: Phase I data; Phase II/III; marketed to treat rheumatoid arthritis

IMNX presented 6-month follow-up data from 12 patients in a 47-patient Phase I study

Read the full 148 word article

How to gain access

Continue reading with a
two-week free trial.